Patents by Inventor Trevor PARRY
Trevor PARRY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11918660Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.Type: GrantFiled: March 8, 2023Date of Patent: March 5, 2024Assignee: Krystal Biotech, Inc.Inventors: Suma Krishnan, Trevor Parry, Dana Michelle Previte, Mary Jane Duermeyer
-
Publication number: 20230338583Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.Type: ApplicationFiled: May 12, 2023Publication date: October 26, 2023Applicant: Krystal Biotech, Inc.Inventors: Suma KRISHNAN, Trevor PARRY, Dana Michelle PREVITE, Mary Jane DUERMEYER
-
Patent number: 11779660Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.Type: GrantFiled: April 1, 2022Date of Patent: October 10, 2023Assignee: Krystal Biotech, Inc.Inventors: Suma Krishnan, Trevor Parry, Dana Michelle Previte, Mary Jane Duermeyer
-
Publication number: 20230241251Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.Type: ApplicationFiled: March 8, 2023Publication date: August 3, 2023Applicant: Krystal Biotech, Inc.Inventors: Suma KRISHNAN, Trevor PARRY, Dana Michelle PREVITE, Mary Jane DUERMEYER
-
Publication number: 20220323613Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.Type: ApplicationFiled: April 1, 2022Publication date: October 13, 2022Applicant: Krystal Biotech, Inc.Inventors: Suma KRISHNAN, Trevor PARRY, Dana Michelle PREVITE, Mary Jane DUERMEYER
-
Publication number: 20210395775Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding a laminin polypeptide (e.g., a human laminin polypeptide) and/or a filaggrin polypeptide (e g , a human filaggrin polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of Junctional Epidermolysis Bullosa); and articles of manufacture or kits thereof.Type: ApplicationFiled: September 25, 2019Publication date: December 23, 2021Applicant: Krystal Biotech, Inc.Inventors: Suma KRISHNAN, Pooja AGARWAL, Trevor PARRY
-
Publication number: 20210317174Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding a cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide (e.g., a human CFTR polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of a chronic lung disease, such as cystic fibrosis); and articles of manufacture or kits thereof.Type: ApplicationFiled: June 23, 2021Publication date: October 14, 2021Inventors: Trevor PARRY, Suma KRISHNAN, Pooja AGARWAL, Jonathan FORMAN
-
Publication number: 20210261649Abstract: The present disclosure provides recombinant nucleic acids (e.g., recombinant herpes viral genomes) comprising one or more polynucleotides encoding an antibody; viruses (e.g., herpes viruses) comprising the recombinant nucleic acids; compositions comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for localized, virus-mediated delivery and expression of the encoded antibody); and articles of manufacture or kits thereof.Type: ApplicationFiled: June 28, 2019Publication date: August 26, 2021Applicant: Krystal Biotech, Inc,Inventors: Trevor PARRY, Pooja AGARWAL, Suma KRISHNAN
-
Publication number: 20210189427Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding a polypeptide (e.g., an inhaled therapeutic polypeptide, such as a human alpha-1-antitrypsin polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for delivering the polypeptide to one or more cells of the respiratory tract and/or for the treatment of a disease affecting the lungs, such as alpha-1-antitrypsin deficiency); and articles of manufacture or kits thereof.Type: ApplicationFiled: December 18, 2020Publication date: June 24, 2021Applicant: Krystal Biotech, Inc.Inventors: Suma KRISHNAN, Trevor Parry, Pooja Agarwal, Sara Artusi, Mladen Yovchev
-
Publication number: 20210087245Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding a cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide (e.g., a human CFTR polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of a chronic lung disease, such as cystic fibrosis); and articles of manufacture or kits thereof.Type: ApplicationFiled: November 6, 2020Publication date: March 25, 2021Applicant: Krystal Biotech, Inc.Inventors: Trevor PARRY, Suma KRISHNAN, Pooja AGARWAL
-
Publication number: 20210045988Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding one or more cosmetic proteins (e.g., one or more human collagen proteins); viruses comprising the recombinant nucleic acids; compositions (e.g., cosmetic formulations) comprising the recombinant nucleic acids and/or viruses; methods of their use; and articles of manufacture or kits thereof.Type: ApplicationFiled: June 29, 2020Publication date: February 18, 2021Applicant: Krystal Biotech, Inc.Inventors: Suma KRISHNAN, Trevor Parry, Pooja Agarwal
-
Patent number: 10829529Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding a cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide (e.g., a human CFTR polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of a chronic lung disease, such as cystic fibrosis); and articles of manufacture or kits thereof.Type: GrantFiled: February 7, 2020Date of Patent: November 10, 2020Assignee: KRYSTAL BIOTECH, INC.Inventors: Trevor Parry, Suma Krishnan, Pooja Agarwal
-
Patent number: 10786438Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding one or more cosmetic proteins (e.g., one or more human collagen proteins); viruses comprising the recombinant nucleic acids; compositions (e.g., cosmetic formulations) comprising the recombinant nucleic acids and/or viruses; methods of their use; and articles of manufacture or kits thereof.Type: GrantFiled: April 26, 2019Date of Patent: September 29, 2020Assignee: Krystal Biotech, Inc.Inventors: Suma Krishnan, Trevor Parry, Pooja Agarwal
-
Publication number: 20200254060Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding a cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide (e.g., a human CFTR polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of a chronic lung disease, such as cystic fibrosis); and articles of manufacture or kits thereof.Type: ApplicationFiled: February 7, 2020Publication date: August 13, 2020Applicant: KRYSTAL BIOTECH, INC.Inventors: TREVOR PARRY, SUMA KRISHNAN, KRISH KRISHNAN, POOJA AGARWAL
-
Publication number: 20190328644Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding one or more cosmetic proteins (e.g., one or more human collagen proteins); viruses comprising the recombinant nucleic acids; compositions (e.g., cosmetic formulations) comprising the recombinant nucleic acids and/or viruses; methods of their use; and articles of manufacture or kits thereof.Type: ApplicationFiled: April 26, 2019Publication date: October 31, 2019Applicant: Krystal Biotech, Inc.Inventors: Suma KRISHNAN, Trevor PARRY, Pooja AGARWAL